(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/LZZ3Pasn2uG.png?ph=true&h=300&w=458 "(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | LZZ3Pasn2uG |
|---|---|
| InChI | InChI=1S/C17H23FN4O/c1-4-15(20-21-19)14-11-17(14,16(23)22(5-2)6-3)12-8-7-9-13(18)10-12/h7-10,14-15H,4-6,11H2,1-3H3/t14-,15-,17+/m0/s1 |
| InChIKey | YGIVMRHYLKKPHP-YQQAZPJKSA-N |
| Mol Weight | 318.4 g/mol |
| Molecular Formula | C17H23FN4O |
| Exact Mass | 318.18559 g/mol |
| Enantiomer InChIKey | YGIVMRHYLKKPHP-INMHGKMJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(1-NAPHTHYL)-2-FORMYL-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
N-[2-(4,4-diphenyl-1-isopropyl-5-oxo-3-pyrrolidinyl)ethyl]phthalimide
3-CYCLOPENTYL-1-ISOPROPYL-4-(2-MORPHOLINOETHYL)-3-PHENYL-2-PYRROLIDINONE, MALEATE (1:1)
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,2R)-1-(1-NAPHTHYL)-2-(HYDROXYMETHYL)-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
1-[4-(DIMETHYLAMINO)-2-ISOPROPYL-2-(1-NAPHTHYL)BUTYRYL]PYRROLIDINE
(E,anti)-3-Methoxycarbonyl-5-methyl-3,4-diphenyl-1-pyrazoline
2,6-Piperidinedione, 1-amino-3-ethyl-3-(pentafluorophenyl)-
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |